In a stunning move, Dr. Peter Marks resigns from the FDA, criticizing health leadership for allowing misinformation to guide vaccination safety policies. His departure highlights ongoing concerns about public health integrity.
Peter Marks, the FDA's Center for Biologics Evaluation and Research head, resigns amid growing concerns over measles outbreaks and vaccine misinformation. His exit raises alarms about future public health initiatives.
In a bold move, the U.S. Department of Health and Human Services is restructuring to save $1.8 billion annually while tackling America's chronic illness epidemic. With a workforce reduction and consolidation of divisions, the new plan promises efficiency and better health outcomes.
In a surprising turn, the Trump administration has terminated key funding for HIV programs aimed at adolescents, raising concerns over the future of HIV prevention efforts in the U.S.
In a bold move, Secretary Kennedy has ordered the removal of a controversial health website as the CDC plans a study linking vaccines to autism, amidst a growing measles outbreak impacting children across the nation.
In a surprising turn, the Trump administration is contemplating cuts to H.I.V. prevention efforts that previously saw significant success. What does this mean for public health?
The Trump administration is reportedly discussing potential cuts to the CDC’s domestic HIV program, sparking concerns over the future of HIV prevention efforts across the U.S. Advocates warn about the implications for testing and outreach as the administration seeks to streamline federal spending.
In a controversial move, NIH officials may be pushing to eliminate mRNA vaccine technology from grant applications, signaling a potential halt in vital medical research. Scientists express fears over job security and funding.
In a surprising turn of events, the White House has withdrawn Dr. Dave Weldon's nomination to lead the CDC just before his Senate confirmation hearing, citing insufficient votes. Weldon expressed shock but also relief at the decision.
In a surprising turn of events, President Trump has withdrawn the nomination of vaccine critic Dave Weldon for the CDC director position. The move comes as Weldon reportedly lacked the Senate votes needed for confirmation, raising questions about vaccine safety debates.
